RICHMOND, Va.--(BUSINESS WIRE)--Insmed, Inc. (NASDAQ:INSM) President and Chief Executive Officer, Geoffrey Allan, Ph. D., testified today at a congressional hearing, “Safe and Affordable Biotech Drugs – The Need for a Generic Pathway.”
RICHMOND, Va.--(BUSINESS WIRE)--Insmed, Inc. (NASDAQ:INSM) President and Chief Executive Officer, Geoffrey Allan, Ph. D., testified today at a congressional hearing, “Safe and Affordable Biotech Drugs – The Need for a Generic Pathway.”
